Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers ; volume:6 ; number:1 ; day:24 ; month:3 ; year:2006 ; pages:1-6 ; date:12.2006
BMC cancer ; 6, Heft 1 (24.3.2006), 1-6, 12.2006
- Creator
-
Copson, Ellen R.
- Contributor
-
White, Helen E.
Blaydes, Jeremy P.
Robinson, David O.
Johnson, Peter W.
Eccles, Diana M.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-6-80
- URN
-
urn:nbn:de:1111-2016030342043
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Copson, Ellen R.
- White, Helen E.
- Blaydes, Jeremy P.
- Robinson, David O.
- Johnson, Peter W.
- Eccles, Diana M.
- SpringerLink (Online service)
Other Objects (12)
Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations
Modifier-Gene in BRCA1/2-Mutationsträgerinnen: SNP-Analyse (single nucleotide polymorphism) in AKAP10, AKAP13 und c-MYC
Modifier-Gene in BRCA1/2-Mutationsträgerinnen: SNP-Analyse (single nucleotide polymorphism) in AKAP10, AKAP13 und c-MYC
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Rapid single nucleotide polymorphism mapping in C. elegans
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
Single Nucleotide Polymorphism Genotyping in Single‐Molecule Electronic Circuits
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations
Modifier-Gene in BRCA1/2-Mutationsträgerinnen: SNP-Analyse (single nucleotide polymorphism) in AKAP10, AKAP13 und c-MYC
Modifier-Gene in BRCA1/2-Mutationsträgerinnen: SNP-Analyse (single nucleotide polymorphism) in AKAP10, AKAP13 und c-MYC
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Rapid single nucleotide polymorphism mapping in C. elegans
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
Single Nucleotide Polymorphism Genotyping in Single‐Molecule Electronic Circuits
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations
Modifier-Gene in BRCA1/2-Mutationsträgerinnen: SNP-Analyse (single nucleotide polymorphism) in AKAP10, AKAP13 und c-MYC
Modifier-Gene in BRCA1/2-Mutationsträgerinnen: SNP-Analyse (single nucleotide polymorphism) in AKAP10, AKAP13 und c-MYC
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Rapid single nucleotide polymorphism mapping in C. elegans
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
Single Nucleotide Polymorphism Genotyping in Single‐Molecule Electronic Circuits
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk